Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Photocure and Artera have launched a joint research initiative to evaluate the ArteraAI Bladder Test using data from Photocure’s blue light cystoscopy registry, aiming to improve diagnostic precision for bladder cancer.
Visage Imaging will highlight its AI optimized One Platform and the latest version of Visage 7 at the SIIM 2026 annual meeting in Pittsburgh, featuring new reporting and digital pathology capabilities.
FinThrive has introduced Denials Prevention Manager, an AI solution that predicts and prevents claim denials before submission by analyzing historical claims data and payer behavior.
Careviso has expanded its national physician and provider network to more than 460,000 enrollments, with plans to exceed 500,000 by the end of 2026. The company also introduced new enhancements to its seeQer platform to improve prior authorization efficiency.
The Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) has introduced the first digital measures set designed for common mental health disorders. The release provides standardized tools for researchers, clinicians, and developers to assess treatment effects and patient outcomes using sensor-based data.
Fullspan Health has launched Healthline AI, a conversational health agent that provides medically reviewed information and guidance to consumers on Healthline.com. The tool features clinical guardrails, privacy protections, and triage protocols to help users make informed health decisions.
Insilica CEO Dr. Thomas Luechtefeld has co-authored a new framework called Evidence-based AI, introducing rigorous standards for AI systems in toxicology.
TFC Taipei Fertility Center in Taiwan has introduced an AI-based embryo assessment model that increases the accuracy of identifying chromosomally normal embryos by up to 24 percent, according to a press release. The system, iDAScore v2.0, analyzes time-lapse imaging and data from embryo development to support clinical decisions in IVF treatment.
Lyric Health has announced a partnership with Scala.AI to enhance its healthcare engagement and care navigation platform using AI. The collaboration will focus on improving member engagement, care coordination, and operational efficiency across virtual care services.
Boston Consulting Group announced a $500 million commitment by 2030 to advance AI for social impact, partnering with Anthropic to support non-profits and philanthropies in areas such as education, health care, and poverty reduction.
Compal Electronics unveiled a biotechnology platform that combines quantum computing and artificial intelligence at COMPUTEX 2026, highlighting collaborations with universities and pharmaceutical firms for drug discovery and manufacturing.
Qaelon Medical and Scialytics have formed a partnership to integrate Qaelon's physiologic gastrointestinal data into Scialytics' AI surgical analytics platform, aiming to improve risk detection and surgical outcomes in colorectal procedures.
OSF HealthCare has expanded its partnership with hellocare.ai to deploy the company's Intelligent Hospital Room platform across all inpatient facilities, integrating virtual nursing, patient safety, and engagement tools into a unified system.
VIDIZMO has introduced the AI Intelligence Hub, a platform that analyzes video, audio, documents, and images together on private or air-gapped infrastructure. The system is designed for sectors such as law enforcement, healthcare, and financial services to deliver sourced and auditable answers.
CorrectSequence Therapeutics announced 15-month follow-up results showing that its CS-206 base editing therapy maintained lasting efficacy and a favorable safety profile in a patient with sickle cell disease, with no vaso-occlusive crises or anemia observed.
First Foundation Labs, a life sciences AI company spun out of Luma Group, announced a collaboration with Microsoft to integrate its clinical and translational reasoning platform into Microsoft Discovery, enhancing AI capabilities for drug development and research.
Ingenix has raised €13 million in seed extension funding led by Sofinnova Partners to scale its Biological Reasoning Engine and launch the Qualified Access Program for pharma and biotech partners.
Adaptive Innovations has raised $50 million in Series A funding led by Felicis, with participation from Bain Capital Ventures and others. The funding will support the expansion of its AI healthcare platform and clinical workforce across new states.
The American Diabetes Association’s Innovation Fund has made a strategic investment in UpDoc to advance its clinical AI platform for chronic disease management and prevention.
WeInfuse has announced a partnership with Trial IQ Technologies to integrate AI tools that help infusion providers launch and manage clinical trial programs, expanding access to research within community care settings.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
